Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 3 | CN | 20 Oct 2023 | |
PSMA-Positive Prostatic Cancer | Phase 3 | CN | 13 Sep 2023 |
Not Applicable | 82 | ([F-18] FlorastaminR PET/CT) | jgkhjybatr(ufqpuhxxpo) = ndylcvzzoo lhamkewbru (fdmfruentu ) View more | - | 01 May 2022 | ||
(Multi-parametric magnetic resonance imaging (mpMRI)) | jgkhjybatr(ufqpuhxxpo) = jhaiqkvhnv lhamkewbru (fdmfruentu ) View more |